Atrium Health Levine Children's Brenner Children's Hospital patient throws first pitch at Dash game
During his time at Brenner Children's Hospital, Jamon discovered his love for art. Prior to his diagnosis, Jamon enjoyed basketball and football, but after staying at the hospital he found a new passion. In February, Jamon worked with the Winston-Salem Dash team to create an ice cream inspired jersey to be worn by players during the Stand Up to Cancer game.
On Saturday, June 14, Jamon threw out the first pitch at the Winston-Salem Dash Stand Up to Cancer game. Later in the game, he was recognized for his bravery battling T-Cell Leukemia. Players also wore a special jersey designed by Jamon. He was excited to see his design come to life on the field.
'No matter what you're going through, keep pushing because God is going to make a way,' Jamon said. 'Trust the group of people supporting you, no matter how big or small your group is. Find a group of people that believe in you as much as you believe in yourself.'
Atrium Health Wake Forest Baptist is a pre-eminent academic learning health system based in Winston-Salem, North Carolina, and part of Advocate Health. Atrium Health Wake Forest Baptist's two main components are an integrated clinical system with locations throughout the region and
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
12 hours ago
- Yahoo
All the benefits of having a G&T over a glass of wine
If you're going to indulge in a drink or two, whether on holiday or in a pub garden, a gin and tonic could be the best option for your health. As a registered nutritionist, Sophie Trotman is bound to repeat the words that we are all so used to hearing: 'I would always recommend that you don't drink at all, or at least lower the amount that you drink,' she says. 'Wines can be quite sugary and contain a lot of sulphates,' Trotman says, which can wreak havoc on your digestive system, while beers 'are high in carbohydrates' and can cause your blood sugar to spike. The heroic G&T, meanwhile, is a drink that 'I often recommend to my clients if they don't want to cut out alcohol entirely,' says Trotman. 'The calories and sugar in a single gin with a light tonic are as low as you're going to get.' This will be welcome news to many. The majority of people in Britain now prefer to drink gin and tonic with friends rather than cups of builders' tea, according to spirit brand Bacardi's cocktail trend report, and the UK constitutes the world's biggest market for gin. So what are the benefits of swapping your regular pint or glass of wine for a G&T? The health benefits of a G&T 1. Fewer calories than beer and wine One shot of gin will provide you with around 50 calories, compared with about 130 calories in a medium glass of red or white wine or the 200-300 calories in a pint of beer. A 200ml serving of light tonic to mix your drink will come in at around 30 calories, keeping a health-conscious G&T under 100 calories to a glass. The average British man drinks 17.6 units of alcohol every week, according to NHS data, the equivalent of eight to nine pints of lager (with beer still being the drink consumed most frequently by men in the UK). Drinking the same number of single-measure G&Ts each week – though it is not recommended that any adult consumes more than 14 units of alcohol in this timeframe – would mean cutting around 900 'empty' calories from your diet and losing a stone within a year. Meanwhile, women who switch from the average nine units or four medium glasses of wine per week to single G&Ts would drink 120 fewer calories. This might not sound like much, but tweaks like this can make all the difference in limiting your party-season weight gain. At this time of year when the units we consume will likely outpace our average for the year, 'a gin and tonic is definitely a better option to manage your weight,' Trotman says. 2. Less sugar and carbs than other contenders A single shot of gin contains zero grams of sugar, as well as no carbohydrates. This is one of the reasons that gin is often the drink of those on a ketogenic diet, as it is less likely to knock your body out of its fat-burning state (though all alcohol will make it harder for your liver to process food). Aside from leading to weight gain, drinking any beverage that has a high carbohydrate content – like lager, with 10-15 grams of carbs to a pint, or cider which has as much as 40 grams a glass – can cause uncomfortable bloating and an upset stomach. A no-carb drink such as gin 'will have less of an impact on your blood sugar levels too,' Trotman says, another factor that makes it a better option for keeping your waistline static (and making sure that you've still got some energy the morning after). And while vodkas and rums typically come mixed in fizzy, sugary drinks, the sugar in a slimline tonic typically comes in at around 7.6 grams per 200ml glass, compared with the 21.2g in 200ml of full-fat Coca Cola. Light rather than diet tonic is ideal with your gin as 'diet tonic will be full of artificial sweeteners that can worsen your health in the long term,' Trotman says. 'So if you're having a few, always opt for a light version and a single shot.' 3. A boost from juniper berries and garnishes Gin is made by brewing a neutral-tasting grain with juniper berries and other botanicals such as lemon peel, coriander seeds, cardamom or thyme. Juniper berries contain flavonoids as well as large amounts of vitamin C, which can improve circulation and help ward off colds, and antioxidants which promote skin regeneration. These berries can also speed up your digestive system and soothe inflammation. While the amount of these goodies left over in a single serving of gin is likely 'negligible', Trotman says, gin can also be infused with ingredients that up its health benefits: some kinds on the market have been paired with large volumes of fruit juice for added vitamin C, while some have been specifically blended to provide micronutrients as well as collagen. Others are brewed with extra juniper berries. G&Ts are also easy to make and serve creatively. A quick health tip is just to 'eat the slice of orange that comes with your drink, because every little does help,' Trotman says, or at home 'you could mix in some cranberry juice for antioxidants or add some blueberries for helpful polyphenols'. 4. Easier to drink in moderation The versatility of a gin and tonic is a major reason why Sophie Trotman recommends it to her clients. Along with a light tonic, 'you can add a lot of ice to make it a long drink that you're able to keep sipping over a longer period,' reducing the total amount of alcohol you drink in the course of an evening. The reduced sugar and artificial sweeteners involved meanwhile will make it easier to stop at just a few, turning down the dial on your cravings and helping you to call it a night earlier. Unlike wine, the leftover bottle of which can call from the fridge on a Monday evening, a G&T takes more effort to make and so it becomes 'easier to have days off,' Trotman says. 'It's also very easy to alternate your G&Ts with glasses of water, which you'll thank yourself for the next day,' Trotman says. For those looking to cut down there are other benefits too. 'It shouldn't be a concern, but if you start on G&Ts and switch to a non-alcoholic version later in the night, there will be no label on your glass and so no peer pressure from anyone else to keep going.' Broaden your horizons with award-winning British journalism. Try The Telegraph free for 1 month with unlimited access to our award-winning website, exclusive app, money-saving offers and more.
Business Journals
a day ago
- Business Journals
The power of together: Hugh Chatham Health officially joins Atrium Health Wake Forest Baptist
Hugh Chatham Health and Atrium Health Wake Forest Baptist announced Hugh Chatham Health has officially joined Atrium Health Wake Forest Baptist, part of the third-largest nonprofit health system in the country, Advocate Health. Additionally, Atrium Health is investing $100 million to ensure access to enhanced resources and expertise is delivered by health care providers who best understand the community's unique needs. 'Hugh Chatham Health believes in the power of our two organizations coming together to enhance patient care, community engagement and innovation in health care delivery,' said Hugh Chatham Health Board of Trustees Chair Cynthia Gonzalez. 'Atrium Health Wake Forest Baptist's deep commitment and experience with serving rural communities like Elkin was one of the key drivers of our decision to select them as our partner.' Atrium Health Wake Forest Baptist was selected, in part, because of its long-standing commitment to rural health care. North Carolina has the second-largest rural population in the United States, with many located in and around the Yadkin Valley area. These rural communities have specific health care challenges, such as recruiting providers and ensuring access to essential services. As part of Atrium Health's commitment, their $100 million investment will allow Hugh Chatham Health to: Implement a new electronic health record, EPIC, to facilitate seamless care coordination between providers at Hugh Chatham Health and Atrium Health Wake Forest Baptist. Advance the recruitment and retention of primary care and specialty care providers to the Yadkin Valley region. Support and expand current clinical programs such as Women's Services, Heart and Vascular and Cancer Care to ensure essential services stay local. Provide professional and career growth opportunities for Hugh Chatham Health team members and providers. 'At a time when rural health care is under pressure across the country, we are stepping up to ensure rural communities have access to leading-edge primary and specialty care close to home – and that's what this partnership with Hugh Chatham Health is going to deliver,' said Eugene A. Woods, CEO of Advocate Health, of which Atrium Health Wake Forest Baptist is a part. "This partnership is about ensuring families in the rural Yadkin Valley have access to the same nationally-recognized medicine, virtual care, and specialty programs in women's and children's health, heart and vascular, cancer, and more – without having to travel far for the care they need and deserve.' 'With our 25-year history of collaboration, this next step naturally builds on our shared commitment to deliver high-quality care, while providing access to advanced resources, cutting-edge technology and clinical expertise,' said Dr. David Zaas, president of Atrium Health Wake Forest Baptist. 'And with Wake Forest University School of Medicine as our academic core, we are excited to bring new opportunities for medical innovation and growth, ensuring long-term health and wellness for the communities we serve.' In addition to the $100 million commitment to Hugh Chatham Health, Atrium Health Wake Forest Baptist has committed $30 million to establish the Yadkin Valley Wellness Foundation, whose mission will advance health and wellness priorities in the community and ensure that the terms and conditions of the broader affiliation are fully met. 'For more than 10 years, I have had the privilege of working with Atrium Health Wake Forest Baptist as a partner on many levels,' said Paul Hammes, CEO of Hugh Chatham Health. 'I know, firsthand, their deep commitment to high-quality, patient-centered care – especially in our rural communities. I am excited about the unlimited possibilities of our future together and the positive impact we can have on this community.' The Hugh Chatham Health board and executive team have committed to keeping the community informed as the process moves forward. Patients and community members are encouraged to visit a dedicated web page to learn more about this partnership and receive timely updates. Atrium Health Wake Forest Baptist is a pre-eminent academic learning health system based in Winston-Salem, North Carolina, and part of Advocate Health. Atrium Health Wake Forest Baptist's two main components are an integrated clinical system with locations throughout the region and , the academic core of Advocate Health and a recognized leader in experiential medical education and groundbreaking research.
Yahoo
2 days ago
- Yahoo
J&J tests direct CAR-T marketing with first Carvykti ad
This story was originally published on BioPharma Dive. To receive daily news and insights, subscribe to our free daily BioPharma Dive newsletter. Available cell therapies for cancer aren't easy treatments to receive. Personalized to each patient, the drugs are complicated and time-consuming to manufacture, and must be delivered and administered on an exacting schedule. And because they come with serious risks, patients need to remain close to the hospital where they were treated for weeks of monitoring. All of these characteristics make Johnson & Johnson's choice to roll out direct-to-consumer advertising for Carvykti, a cell therapy it sells for the blood cancer multiple myeloma, somewhat unexpected. The ad, which will air on streaming services like YouTube, Paramount and Roku, is J&J's first for the drug and a rare instance of DTC marketing for this kind of cell therapy, known as CAR-T. According to June Lanoue, J&J's head of U.S. hematology, the company aims to raise awareness about cell therapy, particularly among patients who may not be receiving care from the kind of specialized academic centers where CAR-T is often given. Carvykti is currently approved in the U.S. to treat multiple myeloma in patients whose disease either relapsed or becomes resistant to treatment after an initial round of therapy. Another CAR-T therapy, called Abecma and sold by Bristol Myers Squibb, is also cleared for this use, but only after two or more prior lines of treatment. Among these 'relapsed, refractory' patients, about half are treated at community oncology centers, Lanoue said. 'The actual awareness level of these options is very low,' she added. 'In the community, if they're not able to get it, doctors are not talking about and therefore they don't have visibility to having a new option.' J&J's choice to advertise is a signal of confidence in its ability to manufacture enough Carvykti to meet any rise in demand. Early on in the drug's launch, production challenges forced the company to limit orders from treating centers. (Bristol Myers ran into similar issues.) 'We feel very confident around production,' said Lanoue. Treatment sites can 'order Carvykti without any constraint.' The launch of the ad is also well-timed, as it comes several weeks after the Food and Drug Administration took steps to improve access to CAR-T treatment broadly. The agency eased some side effect reporting requirements and lessened the time it mandates patients stay near their treating facility for monitoring. It also said patients could resume driving or operating machinery sooner after treatment than previously prescribed. 'We think it will give more opportunity to more patients who [live at] a little bit further distance to be able to receive Carvykti,' Lanoue said. J&J's 120-second ad introduces a composite patient, 'Marvin,' and describes the heavy burden of injections and pills typically used to control multiple myeloma. Carvykti, by contrast, is a one-time infusion that can deliver lasting benefits in some. Recent follow-up data from an early study of around 100 patients treated with Carvykti showed that, at five years, one-third had not yet experienced disease progression. A story published in June by The New York Times that highlighted these findings led to more patients requesting information about Carvykti, according to Lanoue. J&J did not share how much it's spending on this marketing campaign, but Lanoue said it is 'significantly less' than what a pharmaceutical company would typically spend on a regular TV advertisement. 'This is not a share of voice play; this is ultra targeted,' she added. Sales of Carvykti reached $439 million in the three months between April and June. The company expects peak annual sales to eventually eclipse $5 billion. Editor's note: After this story was published, J&J updated the list of streaming services where its ad will appear and removed Hulu for the time being. Recommended Reading FDA takes major step to ease access to CAR-T therapy Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
